Research thrusts

Tissue engineering and biofabrication

The Ozdoganlar Lab develops manufacturing-enabled technologies to engineer functional biological tissues and tissue-on-chip platforms
Microneedle systems (intradermal and transdermal delivery and sampling)

The Ozdoganlar Lab develops next-generation microneedle systems that enable painless, precise, minimally invasive delivery and sampling through skin.
Translational medical devices and integrated platforms

The Ozdoganlar Lab develops manufacturing-enabled, clinically oriented medical device platforms that integrate microfabricated components, sensing/actuation, packaging, and workflows into deployable systems (handheld, wearable, or implantable).
Biointegrated systems (implantable, ingestible, wearable, and soft/stretchable devices)

The Ozdoganlar Lab develops biointegrated device platforms that interface with the body for continuous sensing and closed-loop therapy, spanning implantable, ingestible, and wearable form factors.
Advanced manufacturing and precision engineering

The Ozdoganlar Lab develops precision manufacturing technologies for micro- and mesoscale components and systems, with deep expertise in micromachining, micromolding, high-precision micro- and mesoscale 3D printing (additive manufacturing), and high-fidelity metrology.
Porous materials and electrodes

The Ozdoganlar Lab develops functional porous material systems in which engineered hierarchical porosity serves as a scaffold to create high-performance electrodes and reactive media.

News

Oct 01

Revolutionizing early cancer detection with at-home technology Opens in new window

An award of up to $26.7 million from the Advanced Research Projects Agency for Health (ARPA-H) has been secured by a CMU-led team to offer an at-home solution to detect more than 30 Stage 1 solid tumor cancers from a simple urine sample.

Dec 20

Taking a chance on ambition Opens in new window

The Dowd Engineering Seed Fund for Graduate Student Fellowships funds innovative research proposals.

Oct 02

Carnegie Mellon lands ARPA-H award for implantable bioelectric medicine project Opens in new window

A CMU-led project team secured an award of up to $42M from ARPA-H to accelerate the development of implantable bioelectronic devices that deliver patient-specific therapy and monitor disease status.

More news from Ozdoganlar Lab